Physician profile
William R Post
NPI 1427059823
$6,692.96
in general payments reported to CMS, 2019-2025
30 companies · $826 in 2025
The $826 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,582 · 2022: $1,237 · 2023: $1,374 · 2024: $1,674 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,873.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $796.23 | 2021-2025 | Inspace, System 9 Cd Nxt |
| Si-Bone, INC. | $657.74 | 2021-2024 | |
| Smith+Nephew, INC. | $456.85 | 2021-2024 | Pico 7, Renasys Go V2 Home |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $421.18 | 2021-2025 | Rexulti |
| Abbvie INC. | $410.73 | 2022-2024 | |
| Bioventus LLC | $348.26 | 2021-2024 | Durolane, Durolane |
| Amgen INC. | $344.56 | 2021-2023 | Repatha |
| Zimvie INC. | $266.81 | 2023 | |
| Convatec INC. | $239.93 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $232.88 | 2024-2025 | Zilretta, Iovera |
| Neurelis, INC. | $228.09 | 2023-2024 | Valtoco |
| Gilead Sciences, INC. | $191.31 | 2021 | |
| Inari Medical, INC. | $183.80 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zimmer Biomet Holdings, INC. | $176.40 | 2021-2025 | Accufill |
| Next Science LLC | $140.80 | 2024 | Xperience, Blastx, Surgx |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $127.13 | 2024 | |
| Janssen Biotech, INC. | $125.00 | 2023 | Erleada |
| Highridge Medical LLC | $123.75 | 2024 | Biomet Ebi Bone Healing System |
| Misonix INC | $123.14 | 2021 | |
| Heron Therapeutics, INC. | $122.11 | 2023 | Zynrelef |
| Pfizer INC. | $120.59 | 2025 | |
| Medical Device Business Services, INC. | $114.30 | 2025 | Stratafix |
| Medtronic, INC. | $111.40 | 2021 | |
| Boston Scientific Corporation | $110.05 | 2024 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.15 | 2022 | |
| Edwards Lifesciences Corporation | $98.42 | 2023 | |
| Argenx US, INC. | $96.67 | 2022 | |
| Hologic Sales and Service, LLC | $86.72 | 2025 | Aptima |
| Kyowa Kirin, INC. | $72.00 | 2025 | |
| Hydrofera LLC | $62.96 | 2025 | Sorbact Other |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Post listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.